WO2012123425A1 - Colle à tissu sur la base de prépolymères contenant des groupes esters - Google Patents

Colle à tissu sur la base de prépolymères contenant des groupes esters Download PDF

Info

Publication number
WO2012123425A1
WO2012123425A1 PCT/EP2012/054297 EP2012054297W WO2012123425A1 WO 2012123425 A1 WO2012123425 A1 WO 2012123425A1 EP 2012054297 W EP2012054297 W EP 2012054297W WO 2012123425 A1 WO2012123425 A1 WO 2012123425A1
Authority
WO
WIPO (PCT)
Prior art keywords
radical
prepolymer
polyurea system
polyol
linear
Prior art date
Application number
PCT/EP2012/054297
Other languages
German (de)
English (en)
Inventor
Heike Heckroth
Christoph Eggert
Original Assignee
Bayer Materialscience Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Materialscience Ag filed Critical Bayer Materialscience Ag
Publication of WO2012123425A1 publication Critical patent/WO2012123425A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00—Polymeric products of isocyanates or isothiocyanates
    • C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/70—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the isocyanates or isothiocyanates used
    • C08G18/72—Polyisocyanates or polyisothiocyanates
    • C08G18/77—Polyisocyanates or polyisothiocyanates having heteroatoms in addition to the isocyanate or isothiocyanate nitrogen and oxygen or sulfur
    • C08G18/771—Polyisocyanates or polyisothiocyanates having heteroatoms in addition to the isocyanate or isothiocyanate nitrogen and oxygen or sulfur oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0015—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0042—Materials resorbable by the body
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00—Polymeric products of isocyanates or isothiocyanates
    • C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/08—Processes
    • C08G18/10—Prepolymer processes involving reaction of isocyanates or isothiocyanates with compounds having active hydrogen in a first reaction step
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions

Definitions

  • the present invention relates to an isocyanate-functional prepolymer for the production of a biodegradable polyurea system, a biodegradable polyurea system obtainable using the prepolymer according to the invention and a dosing system for the application of the polyurea system.
  • tissue adhesives Various materials used as tissue adhesives are commercially available. These include cyanoacrylates Dermabond® ® (octyl-2-cyanoacrylate) and histoacryl Blue ® (butyl cyanoacrylate). The prerequisite for efficient bonding of cyanoacrylates, however, are dry substrates. With heavy bleeding such adhesives fail.
  • biological adhesives such as BioGlue ® , a mixture of glutaraldehyde and bovine serum albumin, various collagen and gelatine-based systems (FloSeal ® ) and fibrin glue (Tissucol) are available. These systems are primarily used for hemostasis (haemostasis).
  • fibrin sealants are characterized by a relatively low adhesive strength and rapid degradation, so that they can only be used for smaller injuries on untended tissue.
  • Collagen and gelatin based systems such as FloSeal ® are for hemostasis only.
  • fibrin and thrombin are derived from human, collagen and gelatin from animal material, there is always a risk of infection in biological systems. Biological materials must also be stored refrigerated, so that use in emergency care such. B. in disaster areas, military insertion, etc. is not possible.
  • QuikClot ® or QuikClot ACS + TM is available, which is a mineral granulate that is brought into the wound in an emergency and leads to coagulation there by removing water. In the case of QuikClot® this is a strongly exothermic reaction leading to burns.
  • QuikClot ACS + TM is a gauze in which the salt is embedded. The system must be firmly pressed onto the wound for hemostasis.
  • WO 2009/106245 A2 discloses the production and use of polyurea systems as tissue adhesives.
  • the systems disclosed herein comprise at least two components. This is an amino-functional aspartic acid ester and an isocyanate-functional prepolymer obtained by reacting aliphatic polyisocyanates with polyester polyols.
  • the two-component polyurea systems described can be used as tissue adhesives for the closure of wounds in human and animal cell aggregates. In this case, a very good adhesive result can be achieved.
  • the polyurea systems are designed to biodegrade within a period of up to 6 months.
  • the ester group cleaved primarily during biodegradation is present in the polyol component of the prepolymer used.
  • the production of a corresponding component is associated with a relatively large effort. It has therefore been desired to provide a novel prepolymer which is more readily available on the one hand and has, on the other hand, an additional or alternative physiologically cleavable functional group.
  • the object of the invention was therefore to provide such a prepolymer.
  • X is a propyl, a butyl or a pentyl radical
  • Y is a linear or branched aliphatic C 2 to C 10 radical
  • a polyurea system is considered degradable under physiological conditions when it dissolves in an isotonic NaCl solution (containing 0.9 weight percent NaCl dissolved in water) at 37 ° C.
  • Suitable isocyanates AI are obtainable, for example, in the following way:
  • the corresponding hydrochloride can be prepared with elimination of water and simultaneous introduction of HCl gas, which is further reacted in situ with the desired alcohol hydrochloride hydrochloride.
  • the resulting dihydrochloride is purified by crystallization and then phosgenated in a suitable solvent.
  • Y is a linear, aliphatic C 2 to C 8, preferably C 2 to C 6 radical and particularly preferably an ethyl, a propyl or a butyl radical.
  • Examples of particularly preferred isocyanates AI are 2-isocyanatoethyl-6-isocyanatohexanoate, 3-isocyanatopropyl-6-isocyanatohexanoate, 3-isocyanatobutyl-6-isocyanatohexanoate,
  • the polyol A2) has a number-average molecular weight of> 400 g / mol, preferably> 4000 and ⁇ 8500 g / mol.
  • the polyol A2) may in particular comprise or consist of a polyester polyol and / or a polyester-polyether polyol and / or a polyether polyol.
  • the polyol A2) may comprise or consist of a polyester polyol and / or a polyester-polyether polyol.
  • the polyester-polyether polyol and / or the polyether polyol may have an ethylene oxide content of> 60 and ⁇ 90 wt .-%.
  • Suitable polyetheresterpolyols can according to the prior art by polycondensation of polycarboxylic acids, anhydrides of polycarboxylic acids, and esters of polycarboxylic acids with volatile alcohols, preferably Cl to C6 monools, such as methanol, ethanol, propanol or butanol, with molar excess, low molecular weight and / or be produced higher molecular weight polyol.
  • polyols containing ether groups may optionally be used in mixtures with other polyols which are free of ether groups.
  • mixtures of the higher molecular weight and the low molecular weight polyols can be used for the synthesis of polyethers.
  • Suitable molar excess low molecular weight polyols are polyols having molecular weights of 62 to 299 daltons, having 2 to 12 carbon atoms and hydroxyl functionalities of at least 2, which may further be branched or unbranched and their hydroxyl groups may be primary or secondary. Such low molecular weight polyols may also have ether groups.
  • Typical representatives are ethylene glycol, 1,2-propanediol, 1,3-propanediol, 1,4-butanediol, 2,3-butanediol, 2-methylpropanediol-1,3, 1,5-pentanediol, 1,6-hexanediol , 3-methylpentanediol-l, 5, 1,8-octanediol, 1, 10-decanediol, 1,12-dodecanediol, cyclohexanediol, diethylene glycol, triethylene glycol and higher homologues, dipropylene glycol, tripropylene glycol and higher homologues, glycerol, 1, 1 , 1-trimethylolpropane, as well as Oligo-tetrahydrofane with hydroxyl end groups.
  • Molar excess high molecular weight polyols are polyols having molecular weights of 300 to 3000 dalton, which can be obtained by ring-opening polymerization of epoxides, preferably ethylene and / or propylene oxide, as well as by acid-catalyzed, ring-opening polymerization of tetrahydrofuran.
  • epoxides preferably ethylene and / or propylene oxide
  • acid-catalyzed, ring-opening polymerization of tetrahydrofuran for ring-opening polymerization of epoxides, either alkali metal hydroxides or double metal cyanide catalysts can be used.
  • Epoxidpolymerisation all at least bifunctional molecules from the group of amines and o.g. low molecular weight polyols can be used. Typical representatives are 1, 1, 1-trimethylolpropane, glycerol, o-TDA, ethylenediamine, propylene glycol-1,2, etc., and water, including mixtures thereof.
  • the structure of the higher molecular weight polyols, as far as hydroxyl-terminated polyalkylene oxides of ethylene oxide and / or propylene oxide are concerned, may be random or blockwise, although mixed blocks may also be present.
  • Polycarboxylic acids are both aliphatic and aromatic carboxylic acids, which may be both cyclic, linear, branched or unbranched and which may have between 4 and 24 carbon atoms.
  • Succinic acid, glutaric acid, adipic acid, sebacic acid, lactic acid, phthalic acid, terephthalic acid, isophthalic acid, trimellitic acid, pyromellitic acid are preferred.
  • Particularly preferred are succinic acid, glutaric acid and adipic acid.
  • the group of polycarboxylic acids also hydroxycarboxylic acids, or their internal anhydrides, such. Caprolactone, lactic acid, hydroxybutyric acid, ricinoleic acid, etc. Also included are monocarboxylic acids, in particular those which have more than 10 carbon atoms, such as soybean oil fatty acid, palm oil fatty acid and peanut oil fatty acid, wherein their share of the total, the polyetheresterpolyol constituent reaction mixture 10 wt. -% should not exceed and, in addition, the concomitant minor functionality is compensated by the concomitant use of at least trifunctional polyols, be it on the side of the low molecular weight or the high molecular weight polyols.
  • monocarboxylic acids in particular those which have more than 10 carbon atoms, such as soybean oil fatty acid, palm oil fatty acid and peanut oil fatty acid, wherein their share of the total, the polyetheresterpolyol constituent reaction mixture 10 wt. -% should not
  • the preparation of the polyetherester polyol is carried out according to the prior art, preferably at elevated temperature in the range from 120 to 250 ° C., preferably initially under atmospheric pressure, later in particular under application of a vacuum of 1 to 100 mbar, preferably but not necessarily using an esterification - or transesterification catalyst, wherein the Reaction is completed so far that the acid number to values of 0.05 to 10 mg KOH / g, preferably from 0, 1 to 3 mg KOH / g and more preferably from 0, 15 to 2.5 mg KOH / g decreases.
  • an inert gas can be used.
  • liquid or gaseous entrainers may also be used.
  • the reaction water can be discharged by using nitrogen as a carrier gas as well as by using an azeotrope-dragging agent such as e.g. Benzene, toluene, xylene, dioxane, etc.
  • Polyether polyols are preferably polyalkylene oxide polyethers based on ethylene oxide and optionally propylene oxide.
  • polyether polyols are preferably based on di- or higher-functional starter molecules such as dihydric or higher-functional alcohols or amines.
  • initiators are water (considered as a diol), ethylene glycol, propylene glycol, butylene glycol, glycerol, TMP, sorbitol, pentaerythritol, triethanolamine, ammonia or ethylenediamine.
  • hydroxyl-containing polycarbonates preferably polycarbonatediols, having number-average molecular weights M n of from 400 to 8000 g / mol, preferably from 600 to 3000 g / mol.
  • carbonic acid derivatives such as diphenyl carbonate, dimethyl carbonate or phosgene
  • polyols preferably diols.
  • diols examples include ethylene glycol, 1,2- and 1,3-propanediol, 1,3- and 1,4-butanediol, 1,6-hexanediol, 1,8-octanediol, neopentyl glycol, 1,4-bishydroxymethylcyclohexane, 2- Methyl-l, 3-propanediol, 2,2,4-Trimethylpentandiol-l, 3, dipropylene glycol, polypropylene glycols, dibutylene glycol, polybutylene glycols, bisphenol A and lactone-modified diols of the aforementioned kind.
  • the thin film distillation is used for this purpose, a prepolymer having a residual monomer content of less than 1 wt .-%, preferably less than 0, 1 wt .-%, most preferably less than 0.03 wt .-% is obtained.
  • stabilizers such as benzoyl chloride, isophthaloyl chloride, dibutyl phosphate, 3-chloropropionic acid or methyl tosylate may be added during the preparation of the prepolymer A).
  • the reaction temperature in the preparation of the prepolymer A) is preferably 20 to 120 ° C and more preferably 60 to 100 ° C.
  • the prepolymer A) preferably has an average NCO content of from 2 to 10% by weight, preferably from 2.5 to 8% by weight, measured according to DIN EN ISO 1 1909.
  • the average NCO functionality of the prepolymer A) is preferably 1.5 to 2.5, more preferably 1.6 to 2.4, even more preferably 1.7 to 2.3, very particularly preferably 1.8 to 2.2 and in particular 2.
  • Another object of the invention is a polyurea system comprising
  • R 2 is a linear or branched C 1 to C 4 alkyl, a cyclopentyl, a cyclohexyl radical, H or a CH 2 COOR 3 radical, wherein R3 is an organic radical that does not have Zerewitinoff active hydrogen,
  • ⁇ For the definition of Zerewitinoff-active hydrogen, reference is made to Römpp Chemie Lexikon, Georg Thieme Verlag Stuttgart.
  • groups having Zerewitinoff-active hydrogen are OH, NH or SH.
  • the polyurea system according to the invention is particularly suitable for sealing, bonding, gluing or covering cell tissue, in particular for arresting the escape of blood or tissue fluids, or for closing leaks in cell tissue. So it can be produced with a fast-curing, elastic and durable bond. This is also degradable under physiological conditions.
  • Ri and optionally R3 are each independently or simultaneously a C l to CIO, preferably a C l to C8, more preferably a C2 to C6 alkyl radical and most preferably a methyl and / or an ethyl radical.
  • Q is a linear or branched, unsubstituted or substituted with hetero atoms also in the chain C 1 to C 10, preferably C 2 to C 8, particularly preferably C 3 to C 6 radical.
  • Q is a (CEb p-O group with p> 2 ⁇ 4 or comprises a CEb group.
  • R 3 is a C 1 to C 6 alkyl radical or H
  • R 4 is an organic radical containing a secondary amino function
  • R5, R5 are each independently an organic radical which does not have Zerewitinoff active hydrogen
  • R7, R ' are each independently a CEb-COORsi residue, where R9 is an organic
  • n, m are each independently> 1 and ⁇ 6 and
  • R5 is a radical of the formula (IV)
  • each independently is an organic radical which has no Zerewitinoff active hydrogen.
  • Rio can be a linear or branched, saturated organic radical optionally substituted by heteroatoms in the chain, in particular a linear or branched, saturated, aliphatic C 1 to C 10, preferably C 2 to C 8 and particularly preferably C 2 to C 6 hydrocarbon radical.
  • RH can preferably be a radical of the formula (V)
  • R 12, R 13 are each, independently of one another or simultaneously a C 1 to C 10, preferably a C 1 to C 8, particularly preferably a C 2 to C 6 alkyl radical and very particularly preferably a methyl and / or an ethyl radical.
  • Such compounds react particularly quickly with the prepolymer to form a three-dimensional polyurea system.
  • R 1 are each a CF b COOR 4 radical in which R 7 is an organic radical which has no Zerewitinoff-active hydrogen.
  • R 7 and optionally R9 can each independently or simultaneously a Cl- to CIO, preferably a Cl to C8, more preferably a C2 to C6 alkyl radical and most preferably a methyl and / or an ethyl radical.
  • Zi and Z2 are each simultaneously an Orb radical.
  • the indices n and m can each independently or simultaneously be> 1 and ⁇ 6, preferably> 1 and ⁇ 4 and particularly preferably 1 or 2.
  • An aminofunctional compound of the formula (VI) is therefore particularly advantageous.
  • R14, R15 are each independently identical or different organic radicals which have no Zerewitinoff-active hydrogen and each independently saturated, linear or branched, optionally also heteroatom-substituted in the chain, organic Res te, which have no Zerewitinoff-active hydrogen are.
  • the radicals Rie, R17, Ris can each independently be linear or branched, in particular saturated, aliphatic Cl to C12, preferably C2 to CIO, especially preferably C3 to C8 and very particularly preferably C3 to C6 hydrocarbon radicals ,
  • Aminofunctional compounds are characterized by the fact that they cure very rapidly with the prepolymer to form a strongly adhesive, elastic and solid polyurea network.
  • the radicals Ru, R15 can each independently be linear or branched organic C 1 to C 10, preferably C 1 to C 8, particularly preferably C 2 to C 6, very particularly preferably C 2 to C 4 radicals and in particular aliphatic hydrocarbon radicals. This compound is characterized by a fast network formation in a reaction with the prepolymer.
  • radicals R ⁇ and R15 are the same and / or in each case the radicals Rie, R17, Ri8 are identical.
  • amino-functional compound B) of the general formula (VII) is also preferred.
  • Z3 is an organic radical, preferably containing a secondary amino function
  • R 19 are identical or different organic radicals which have no Zerewitinoff active hydrogen and
  • s is an integer of at least 2
  • s in the formula (VII) is an integer> 2 ⁇ 4 and most preferably equal to 2.
  • Z3 may in particular be a radical of the formula (VIII)
  • each independently of one another are an organic radical which has no Zereptinoff-active hydrogen.
  • R21, R22 each independently or simultaneously a linear or branched, optionally substituted in the chain with heteroatoms saturated saturated organic radical, in particular a linear or branched, saturated, aliphatic C 1 to CIO, preferably C2 to C8 and most preferably C2 to C6 are hydrocarbon radical.
  • Such polyurea systems cure very quickly.
  • radicals R 19, R 20 are each independently linear or branched C 1 to C 10, preferably C 1 to C 8, particularly preferably C 2 to C 6, very particularly preferably C 2 to C 4 organic radicals and in particular aliphatic radicals Hydrocarbon radicals are.
  • particularly suitable radicals are methyl, ethyl, propyl and butyl. It is furthermore preferred if the polyurea system according to the invention comprises an organic filler C).
  • the organic fillers C) may preferably be hydroxy-functional compounds, in particular polyether polyols having repeating ethylene oxide units.
  • the fillers C) have an average OH functionality of from 1.5 to 3, preferably from 1.8 to 2.2 and particularly preferably from 2.
  • liquid polyethylene glycols such as PEG 200 to PEG 600
  • their mono- or dialkyl ethers such as PEG 500 dimethyl ether
  • liquid polyether and polyester polyols liquid polyesters
  • Ultramoll (Lanxess AG, Leverkusen, DE) and glycerine and its liquid derivatives, such as Triacetin (Lanxess AG, Leverkusen, DE) are used.
  • polyethylene glycols which have a number-average molecular weight of from 100 to 1000 g / mol, particularly preferably from 200 to 400 g / mol, are used as organic fillers.
  • the viscosity of the organic fillers measured according to DIN 53019 at 23 ° C. is preferably from 10 to 20,000 mPas, more preferably from 50 to 4000 mPas and particularly preferably from 50 to 2000 mPas.
  • the polyurea system may additionally comprise water and / or a tertiary amine D).
  • component D) is a tertiary amine of the general formula (IX) R 23
  • Pv23, Pv24, Pv25 independently of one another can be alkyl or heteroalkyl radicals having heteroatoms in the alkyl chain or at the end thereof, or R7 and R 'together with the nitrogen atom carrying them can form an aliphatic, unsaturated or aromatic heterocycle which optionally contains further heteroatoms may contain.
  • the tertiary amine may in particular be a compound selected from the group triethanolamine, tetrakis (2-hydroxyethyl) ethylenediamine, N, N-dimethyl-2- (4-methylpiperazin-1-yl) ethanamine, 2 - ⁇ [2- (Dimethylamino) ethyl] (methyl) amino ⁇ ethanol, 3,3 ', 3 "- (l, 3,5-triazinane-l, 3,5-triyl) tris (N, N-dimethyl-propane-1-amine ) act.
  • component D) contains 0.2 to 2.0% by weight of water and / or 0.1 to 1.0% by weight of the tertiary amine.
  • the polyurea system may also comprise a pharmacologically active compound E), in particular an analgesic with or without antiinflammatory activity, an antiinflammatory drug, an antimicrobial active substance or an antimycotic.
  • a pharmacologically active compound E in particular an analgesic with or without antiinflammatory activity, an antiinflammatory drug, an antimicrobial active substance or an antimycotic.
  • the polyurea system according to the invention can also very particularly preferably be used for the production of a means for closing, joining, gluing or covering human or animal cell tissue. It can be used to produce fast-curing, highly adherent, transparent, flexible and biocompatible adhesive bonds that degrade under physiological conditions.
  • Yet another object of the invention is metering system with two chambers for a polyurea system according to the invention, wherein in one chamber the prepolymer A) and in the other chamber, the amino-functional compound B) and optionally the filler C), the water and / or the amine D) and the active compound E) are contained.
  • a metering system is particularly suitable for applying the polyurea system as an adhesive to tissue. Examples:
  • the molecular weights were determined by gel permeation chromatography (GPC) as follows: The calibration was carried out with polystyrene standards having molecular weights of Mp 1,000,000 to 162. The eluent was tetrahydrofuran p.A. used. The following parameters were observed during the double measurement: Degassing: Online - Degasser; Flow: 1 ml / min; Analysis time: 45 minutes; Detectors: refractometer and UV detector; Injection volume: 100 ⁇ - 200 ⁇ . The calculation of the molecular weight averages Mw; Mn and Mp and the polydispersity Mw / Mn were software-based. Baseline points and evaluation limits were determined in accordance with DIN 55672 Part 1.
  • NCO content Unless expressly stated otherwise, the NCO content was determined volumetrically in accordance with DIN-EN ISO 1 1909.
  • Viscosity The viscosity was determined according to ISO 3219 at 23 ° C.
  • Residual monomer content The residual monomer content was determined according to DIN ISO 17025.
  • HDI Hexamethylene diisocyanate (Bayer MaterialScience AG)
  • the dihydrochloride was slurried in chlorobenzene to a 10-15% suspension and phosgenated at 100-125 ° C until a clear solution had formed.
  • the solvent was distilled off and the diisocyanate was purified by thin film distillation.
  • 0.54 g aspartate A was well mixed with 4 g of prepolymer 1 and cured in a tube (diameter 0.5 cm, length 2 cm).
  • the resulting test specimen was in each case 10 ml buffer solution (pH 7.4, Aldrich P-5368) for 48 h at 60 ° C in a shaking incubator with 150 U / min swelled.
  • the sample was then rinsed with deionized water and blotted dry. The weight of the sample was determined as takeoff weight.
  • the sample was further shaken in 10 ml of buffer solution (pH 7.4, Aldrich P-5368) at 60 ° C in a shaking incubator under the same conditions. The weight of the sample was determined weekly.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Surgery (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Emergency Medicine (AREA)
  • Polyurethanes Or Polyureas (AREA)

Abstract

L'invention concerne un prépolymère à fonction isocyanate (A), pouvant être obtenu par réaction d'un isocyanate A1) de la formule générale (I), dans laquelle X est un radical propyle, butyle ou pentyle et Y un radical aliphatique linéaire ou ramifié en C2 à C10, avec un polyol A2) d'une fonctionnalité OH de 2 à 6, servant à la préparation d'un système de polyurée biodégradable. L'invention concerne également un système de polyurée biodégradable pouvant être obtenu en utilisant du prépolymère selon l'invention, ainsi qu'un système de dosage pour l'application du système de polyurée.
PCT/EP2012/054297 2011-03-16 2012-03-12 Colle à tissu sur la base de prépolymères contenant des groupes esters WO2012123425A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11158558.4 2011-03-16
EP11158558 2011-03-16

Publications (1)

Publication Number Publication Date
WO2012123425A1 true WO2012123425A1 (fr) 2012-09-20

Family

ID=44080259

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2012/054297 WO2012123425A1 (fr) 2011-03-16 2012-03-12 Colle à tissu sur la base de prépolymères contenant des groupes esters

Country Status (1)

Country Link
WO (1) WO2012123425A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2933253A1 (fr) * 2014-04-17 2015-10-21 3V SIGMA S.p.A Azurants optiques a base de stilbene

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1903579A1 (de) * 1968-03-15 1969-10-09 Allied Chem Diamine,Salze davon und Diisocyanate sowie Verfahren zu ihrer Herstellung
CA2219545A1 (fr) * 1997-10-28 1999-04-28 Kimberly Woodhouse Matieres biodegradables pour pansements
WO2009106245A2 (fr) 2008-02-28 2009-09-03 Bayer Materialscience Ag Barrières anti-adhérences postopératoires

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1903579A1 (de) * 1968-03-15 1969-10-09 Allied Chem Diamine,Salze davon und Diisocyanate sowie Verfahren zu ihrer Herstellung
CA2219545A1 (fr) * 1997-10-28 1999-04-28 Kimberly Woodhouse Matieres biodegradables pour pansements
WO2009106245A2 (fr) 2008-02-28 2009-09-03 Bayer Materialscience Ag Barrières anti-adhérences postopératoires

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
"Römpp Chemie Lexikon", GEORG THIEME VERLAG

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2933253A1 (fr) * 2014-04-17 2015-10-21 3V SIGMA S.p.A Azurants optiques a base de stilbene
US9487503B2 (en) 2014-04-17 2016-11-08 3V Sigma S.P.A. Stilbene optical brighteners

Similar Documents

Publication Publication Date Title
EP2454303B1 (fr) Adhésif tissulaire à base de polyurée
EP3097929B1 (fr) Barrières d'adhésion postopératoires
EP3385294B1 (fr) Prépolymère à isocyanate fonctionnel pour un adhésif tissulaire biodégradable
EP2307063B1 (fr) Colles médicales destinées à arrêter des saignements graves et à étanchéifier des fuites
EP2794798B1 (fr) Polymère hydroxy-amino et son utilisation dans des adhésifs de tissu à base de polyurée polyuréthane
EP2725044B1 (fr) Prépolymère à terminaison alkoxysilane à base de polyols de polyéther carbonate pour mousse à atomiser
EP2802612B1 (fr) Durcissant (à base d'aspartate) modifié par ester d'acides bêta-aminés et son utilisation dans des adhésifs tissulaires en polyurée
JP2008527108A (ja) ジイソシアネート末端マクロマー、およびその、内部接着剤またはシーラントとして使用するための調剤
EP2673310B1 (fr) Adhésif tissulaire à base d'aspartates modifiés par azote
EP2376133B1 (fr) Colle médicale utilisée en chirurgie
WO2013104564A1 (fr) Ester d'acide bêta-aminé et son utilisation
EP2673311B1 (fr) Adhésif pour tissu à base d'aspartate trifonctionnel
EP2699614B1 (fr) Adhésif tissulaire ayant un durcissement accéléré
WO2012123425A1 (fr) Colle à tissu sur la base de prépolymères contenant des groupes esters
EP2699615B1 (fr) Adhésif médical pour stopper des saignements
JP2018527080A (ja) 半月板修復用接着剤
WO2012107376A1 (fr) Adhésifs tissulaires à base de triacétals substitués par amino
WO2013004653A1 (fr) Structure en couches pour le colmatage de fuites de tissu

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12707817

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 12707817

Country of ref document: EP

Kind code of ref document: A1